METHOD OF TREATING COVID-19 IN CHILDREN AT RISK OF SEVERE CLINICAL COURSE OF DISEASE Russian patent published in 2024 - IPC A61K39/395 A61P31/04 A61P31/14 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to infectious diseases and paediatrics. Performing antiviral, symptomatic, antibacterial therapy with underlying therapy for the underlying disease, wherein the child is additionally administered a preparation Human immunoglobulin against COVID-19 in dose of 0.3–1.1 mg/kg of body in amount of 1–3 infusions. Infusions are carried out every 24–72 hours if there is a positive control result of IgG to SARS-CoV-2. Control of IgG to SARS-CoV-2 is carried out by means of PCR test or rapid test for SARS-CoV-2. Treatment according to the declared method is carried out with virus release of SARS-CoV-2, lasting more than 10 days, regardless of the form of severity of the disease and manifestation of syndromes.

EFFECT: method provides a wider range of methods for treating coronavirus infection COVID-19 in children, promotes a more favourable clinical course of the disease and is an effective and safe method of treatment, enables to prevent disease progression in children at risk of severe course of COVID-19 and to eliminate SARS-CoV-2 virus from the body in immunocompromised children.

3 cl, 11 tbl, 3 ex